Research & Development — a DSIR-approved innovation centre
Biodeal's DSIR-approved R&D department is staffed by experienced pharmaceutical scientists and formulation experts who take your vision from concept to regulatory-compliant commercial reality — across pharma, nutraceuticals, nasal sprays, injectables and herbals.
Innovation is at the core of our CDMO value
Whether you arrive with a validated molecule seeking an optimal delivery system, or a new wellness concept that needs formulating from scratch, Biodeal's R&D team works closely alongside you to develop products that are novel, stable and commercially viable — not just technically correct.
Because development, regulatory and manufacturing sit under one roof, the formula that succeeds in the lab is the formula that scales to commercial batches. That continuity is what turns a promising idea into a registered, exportable product — with no handover gaps along the way.
Five categories
Pharma, nutraceutical, nasal spray, injectable and herbal formulation under one team.
Stable by design
ICH-guided stability built into development, not bolted on before filing.
One continuum
Concept, dossier and scale-up handled by one accountable partner.
Seven services, one development team
From first formulation through to commercial scale-up — Biodeal's DSIR-approved R&D Centre covers the full development pathway under a single quality system.
New Formulation Development
Pharma, nutraceutical, nasal spray, injectable and herbal formulation design and development.
Stability Studies
ICH guideline-compliant accelerated and long-term studies across climatic zones I, II, III and IV.
Analytical Method Dev & Validation
HPLC, GC, dissolution, content uniformity and microbiological method development and validation.
Bioequivalence Support
Comparative dissolution studies and BE study support for generic pharmaceutical registration.
Regulatory Dossier Preparation
CTD / ACTD dossier preparation for both Indian and international market submissions.
Technology Transfer & Scale-Up
Seamless transfer from R&D to pilot batch to full commercial manufacturing.
Nasal Spray R&D
Specialist intranasal delivery optimisation — pump selection and fill-volume specification.
Five stages, one continuum
A single accountable team carries every project from the first formulation brief through to a validated, transfer-ready commercial process.
Concept & Feasibility
Scientists assess the molecule or wellness concept, target profile and the most suitable delivery system.
FeasibilityFormulation Development
Novel, stable formulations developed at the DSIR-approved R&D Centre across all five categories.
R&D centreStability & Analytics
ICH-compliant stability studies with validated HPLC, GC and dissolution analytical methods.
ICH zones I–IVRegulatory Dossier
CTD / ACTD dossier preparation and bioequivalence support for Indian and international markets.
Regulatory affairsTech Transfer & Scale-Up
Seamless transfer from R&D to pilot batch to validated commercial manufacturing.
Commercial scaleThis is how we develop. See whatwe're building.
This page covers the R&D services we engage on. Our Innovation pipeline is where the deeper science lives — nasal-delivery technology, DPI development and the formulations moving through our pipeline.
Recognised capability, measurable advantage
DSIR approval is more than a credential — it signals proven scientific capability and unlocks real commercial benefit for the programmes we run with you.
Government recognised
Recognised by the Department of Scientific and Industrial Research, Government of India — confirming the scientific capability of the R&D unit.
ICH-compliant studies
Accelerated and long-term stability across climatic zones I–IV, with validated analytical methods backing every result.
Concept to commercial
One team from feasibility to scale-up — so the formulation that succeeds in the lab is the one that reaches the market.
R&D capability, answered
The questions clients ask most often before starting a development project with Biodeal.
What does Biodeal's R&D service include?
Biodeal's DSIR-approved R&D Centre provides new formulation development across pharma, nutraceutical, nasal spray, injectable and herbal categories; ICH-compliant stability studies; analytical method development and validation; regulatory dossier preparation (CTD/ACTD); bioequivalence support; and technology transfer and scale-up.
What is a DSIR-approved R&D Centre?
A DSIR-approved R&D Centre is a research facility recognised by the Department of Scientific and Industrial Research, Government of India. It confirms the scientific capability of the R&D unit and qualifies the company for weighted tax deduction on R&D expenditure under Indian income tax law.
Discuss your development project
Tell us your molecule, concept or wellness idea and your target markets — our R&D team responds with a development pathway and a capabilities brief tailored to your project.